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Volume 49, Number 5S Rapid Paced Paper Sessions 49SObjectives: To compare the outcomes of surgeon-modified fenestrat-
ed-branched stent grafts (mFBSG) and abdominal debranching (AD) in
patients unfit for conventional open repair of complex abdominal (AAA) and
thoracoabdominal aortic aneurysms (TAAA).
Methods: We reviewed the outcomes of 35 high-risk patients (30
male, 5 female; median age 75 years) treated for large (7.21 cm) complex
AAA and TAAA between 2006 and 2008. Fifteen patients had AD of 43
vessels (26 mesenteric, 17 renal) with aortic stent grafting. Twenty patients
had 1 to 4-vesselmFBSG with branch artery stenting of 52 vessels (32 renal,
18 mesenteric, 2 hypogastric). End-points were mortality, morbidity, pa-
tency, endoleak and re-intervention rates.
Results:mFBSGpatients had higher comorbidity scores (165 vs 123;
P.03) and more (P.05) stress-induced cardiac ischemia (60% vs 27%), renal
insufficiency (65% vs 20%) and trans-renal aneurysm extension (100% vs 67%).
Thenumber of target vessels per patient (2.81)was similar in bothgroups, but
AD patients had more thoracic extension (80% vs 32%; P.05). Technical
success for branch artery stenting was 98% (51/52). mFBSG required more
(P.05) fluoroscopy time (13520min) and contrast dose (10589ml),
but less operative time (15149 min), blood loss (10.8 L) and fluid
requirement (72 L). There was 1 (5%) operative death aftermFBSG and 3
(20%) after AD (P0.19). Patients treated withmFBSG had less complications
(40% vs 73%; P.05), similar paraplegia rate (5% vs 13%; P.39) and decreased
hospital stay (107 days; P.05). Type I endoleak was noted in 3mFBSG (2
resolved) and in 4 AD patients (1 resolved). There was no difference in 1-year
freedom from endoleak (839% vs 749%), re-intervention (839% vs
589%), target vessel patency (959% vs 982%) and survival (728% vs
719%) inmFBSG vs AD patients. Sac shrinkage ( 5mm)was noted in 7 of 9
(78%) mFBSG patients with 6 months follow up, and in none of the AD
patients (P.02). There were nomigrations, component separations, fractures,
or aneurysm ruptures aftermFBSG.
Conclusion: Surgeon-modified fenestrated and branched stent grafts can
be performed with high procedural success in high-risk patients with complex
AAA and TAAA. This study supports the use ofmFBSG as an alternative to AD
in patients who are suitable candidates for both techniques.
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Background: Growth of small abdominal aortic aneurysms (AAAs) is
frequently associated with aortic neck and iliac artery (IA) changes during
surveillance. The purpose of this study was to determine the effects of aortic
neck and IA changes on anatomic suitability for endovascular aortic aneu-
rysm repair (EVAR ) during long-term follow-up, particularly of small AAAs
with marginal neck morphology (length 15 mm and diameter28 mm).
Methods: We studied 62 patients with small AAAs (diameter, 4 cm to
5.4 cm) under surveillance with long-term follow-up by CT angiography
and 3D reconstructions. The mean follow-up duration was 36 months
(interquartile range [IQR], 16-53 months). AAA morphology and changes
were measured according to SVS reporting standards. Suitability for EVAR
was determined by neck anatomy (diameter, length and angulations, throm-
bosis), IA morphology and all AAA angulations.
Results: Themedian age of the study cohort was 74 years (IQR, 65-77
years). Marginal necks were present in 22 (35%) small AAAs on initial CTA.
Of these AAAs with marginal necks, 74% were considered suitable for
EVAR. Themedian AAA diameter increased from 44.5mm (IQR, 41-48) to
51.1 mm (IQR, 46-55). The aortic neck diameter increased from 23.0 mm
to 25.9 mm (P.001), whereas neck length decreased from 26.5 mm to
19.0 mm (P.001). No significant changes in aortic and IA morphology/
angulation occurred. Overall, the anatomic suitability for endovascular
repair significantly changed during the study period (81% vs 69%; McNemar
test, P.001). Of note, 45% of AAAs with marginal neck morphology vs. 3%
of those with adequate necks were not suitable for EVAR at the end of
follow-up (P.001). In fact, AAAs with marginal necks had a 17-fold
increased risk of losing anatomic suitability for EVAR during surveillance
(odds ratio, 16.8; 95% confidence interval, 4.0-69).
Conclusions: Significant changes in aortic neck morphology and EVAR
suitability occur during long-term surveillance of small AAAs. EVAR suitability
is primarily affected in small AAAs with marginal neck morphology. Our data
indicate that early elective EVAR for small AAAs withmarginal necks is justified
when this is the preferred treatment option, as ongoing surveillance in such
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Objective: Widespread community adoption of EVAR has led to
changing referral patterns to academic centers, now consisting of more
patients with unsuitable anatomy defined in the instructions for use (IFU) of
endografts. Treatment of AAAs with high-risk anatomy (neck
length15mm, neck angle 60o) using commercially available devices has
become more common with increasing institutional experience. We exam-
ined whether placement of approved devices in short angled necks provides
acceptable durability at early and intermediate time points.
Methods: 218 patients (197 men, 21 women) underwent elective
EVAR at a single academic center from 2004-2007 with at least 1 year
follow-up. All available pre- and post-op imaging and clinical follow-up were
reviewed. Patients were divided into suitable anatomy (IFU) and high-risk
(non-IFU) categories.
Results: IFU (n143) patients underwent repair with Excluder (40%),
AneuRx (34%), and Zenith (26%) devices, while non-IFU (n75) were
treated primarily with Zenith (57%). Demographics between the groups
were similar, and anatomic details are in Table 1. Operative mortality was
1.4% and morbidity was 11.9%, with mean follow-up of 24 months (range
1-60). Non-IFU patients tended to have larger sac diameters, shorter,
conical, and more angled necks, and were more likely to require suprarenal
fixation, placement of proximal cuffs, and increased fluoroscopy time. There
were no early or late surgical conversions. Rates of migration, endoleak, need
for 2nd procedures, sac regression, and freedom from aneurysm-related
death were similar between the groups.
Conclusions: EVAR can be performed safely in high-risk patients with
unfavorable neck anatomy using commercially-available endografts. Supra-
renal fixation and proximal cuffs are often required for optimal results.
Mid-term outcomes are comparable to those achieved in patients with
suitable anatomy using the same devices. Long-term follow-up will continue










AAA max diameter (mm) 58.5 56.9 61.5 .002
Neck length (mm) 24 25 13 .0001
% Neck length  10mm 10.6% 0% 30.7% .0001
% Conical necks 33.5% 25.2% 49.3% .0001
Neck angulation (deg) 30 15 59 .0001
% Neck angle 60 deg 23.8% 0.7% 68% .0001
Associated iliac aneurysm 24.8% 25.9% 22.7% NS
Procedural
characteristics
% Suprarenal fixation use 37.2% 26.6% 57.3% .0001
% Proximal cuff use 6.0% 2.1% 13.3% .003
Estimated blood loss
(mL)
357 347 377 NS
Fluoroscopy time (min) 27.1 24.7 31.3 .02
Contrast use (mL) 118 118 119 NS
Mid-term Outcomes
% Migration10mm 2.3% 2.1% 2.7% NS
% Type I endoleak 5.5% 5.6% 5.3% NS
% Type II endoleak 37.6% 41.3% 30.7% NS
% 2nd procedure 16.5% 17.5% 14.7% NS
Mean sac regression
(mm)












Overall survival 2-year 84.8% 88.2% NS
3-year 81.6 % 77.9% NS
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